Among others, the programmed death ligand-1/programmed death-1 (PD-L1/PD-1) signaling axis impairs effector T cell immunity and enhances immune tolerance of tumor cells, playing a pivotal role in attenuating anti-tumor responses in both mouse and human cancers [4, 5]. This evidence concerns the gene CD274 and neoplasm.